世界のA型肝炎ウイルス細胞受容体2市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Hepatitis A Virus Cellular Receptor 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14996 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、A型肝炎ウイルス細胞受容体2のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。A型肝炎ウイルス細胞受容体2の種類別市場規模（IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他）、用途別市場規模（結腸がん、骨髄異形成症候群、非小細胞肺がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・A型肝炎ウイルス細胞受容体2の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他 ・用途別分析2016年-2026年：結腸がん、骨髄異形成症候群、非小細胞肺がん、その他 ・A型肝炎ウイルス細胞受容体2の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・A型肝炎ウイルス細胞受容体2のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・A型肝炎ウイルス細胞受容体2のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・A型肝炎ウイルス細胞受容体2の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・A型肝炎ウイルス細胞受容体2の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Hepatitis A Virus Cellular Receptor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hepatitis A Virus Cellular Receptor 2 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Hepatitis A Virus Cellular Receptor 2 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Hepatitis A Virus Cellular Receptor 2 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
IMM-1802
LY-3321367
MCLA-134
CA-170
CA-327
ENUM-005
Others

Market segment by Application, can be divided into
Colon Cancer
Myelodysplastic
Non-Small Cell Lung Cancer
Others

Market segment by players, this report covers
Aurigene Discovery Technologies Ltd
BeiGene Ltd
Eli Lilly and Co
Enumeral Biomedical Holdings Inc
Incyte Corp
Interprotein Corp
Jounce Therapeutics Inc
Merus NV
Novartis AG
Sorrento Therapeutics Inc
Sutro Biopharma Inc
Tesaro Inc
Trellis Bioscience Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hepatitis A Virus Cellular Receptor 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hepatitis A Virus Cellular Receptor 2, with revenue, gross margin and global market share of Hepatitis A Virus Cellular Receptor 2 from 2019 to 2021.
Chapter 3, the Hepatitis A Virus Cellular Receptor 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Hepatitis A Virus Cellular Receptor 2 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Hepatitis A Virus Cellular Receptor 2 research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Hepatitis A Virus Cellular Receptor 2
1.2 Classification of Hepatitis A Virus Cellular Receptor 2 by Type
1.2.1 Overview: Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type in 2020
1.2.3 IMM-1802
1.2.4 LY-3321367
1.2.5 MCLA-134
1.2.6 CA-170
1.2.7 CA-327
1.2.8 ENUM-005
1.2.9 Others
1.3 Global Hepatitis A Virus Cellular Receptor 2 Market by Application
1.3.1 Overview: Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Colon Cancer
1.3.3 Myelodysplastic
1.3.4 Non-Small Cell Lung Cancer
1.3.5 Others
1.4 Global Hepatitis A Virus Cellular Receptor 2 Market Size & Forecast
1.5 Global Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast by Region
1.5.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region, (2016-2021)
1.5.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.6 South America Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis A Virus Cellular Receptor 2 Market Drivers
1.6.2 Hepatitis A Virus Cellular Receptor 2 Market Restraints
1.6.3 Hepatitis A Virus Cellular Receptor 2 Trends Analysis
2 Company Profiles
2.1 Aurigene Discovery Technologies Ltd
2.1.1 Aurigene Discovery Technologies Ltd Details
2.1.2 Aurigene Discovery Technologies Ltd Major Business
2.1.3 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.1.4 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aurigene Discovery Technologies Ltd Recent Developments and Future Plans
2.2 BeiGene Ltd
2.2.1 BeiGene Ltd Details
2.2.2 BeiGene Ltd Major Business
2.2.3 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.2.4 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BeiGene Ltd Recent Developments and Future Plans
2.3 Eli Lilly and Co
2.3.1 Eli Lilly and Co Details
2.3.2 Eli Lilly and Co Major Business
2.3.3 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.3.4 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly and Co Recent Developments and Future Plans
2.4 Enumeral Biomedical Holdings Inc
2.4.1 Enumeral Biomedical Holdings Inc Details
2.4.2 Enumeral Biomedical Holdings Inc Major Business
2.4.3 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.4.4 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Enumeral Biomedical Holdings Inc Recent Developments and Future Plans
2.5 Incyte Corp
2.5.1 Incyte Corp Details
2.5.2 Incyte Corp Major Business
2.5.3 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.5.4 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Incyte Corp Recent Developments and Future Plans
2.6 Interprotein Corp
2.6.1 Interprotein Corp Details
2.6.2 Interprotein Corp Major Business
2.6.3 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.6.4 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Interprotein Corp Recent Developments and Future Plans
2.7 Jounce Therapeutics Inc
2.7.1 Jounce Therapeutics Inc Details
2.7.2 Jounce Therapeutics Inc Major Business
2.7.3 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.7.4 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Jounce Therapeutics Inc Recent Developments and Future Plans
2.8 Merus NV
2.8.1 Merus NV Details
2.8.2 Merus NV Major Business
2.8.3 Merus NV Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.8.4 Merus NV Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merus NV Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.9.4 Novartis AG Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 Sorrento Therapeutics Inc
2.10.1 Sorrento Therapeutics Inc Details
2.10.2 Sorrento Therapeutics Inc Major Business
2.10.3 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.10.4 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sorrento Therapeutics Inc Recent Developments and Future Plans
2.11 Sutro Biopharma Inc
2.11.1 Sutro Biopharma Inc Details
2.11.2 Sutro Biopharma Inc Major Business
2.11.3 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.11.4 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sutro Biopharma Inc Recent Developments and Future Plans
2.12 Tesaro Inc
2.12.1 Tesaro Inc Details
2.12.2 Tesaro Inc Major Business
2.12.3 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.12.4 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Tesaro Inc Recent Developments and Future Plans
2.13 Trellis Bioscience Inc
2.13.1 Trellis Bioscience Inc Details
2.13.2 Trellis Bioscience Inc Major Business
2.13.3 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.13.4 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Trellis Bioscience Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Hepatitis A Virus Cellular Receptor 2 Players Market Share
3.2.2 Top 10 Hepatitis A Virus Cellular Receptor 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Hepatitis A Virus Cellular Receptor 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Hepatitis A Virus Cellular Receptor 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application (2016-2021)
5.2 Hepatitis A Virus Cellular Receptor 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
6.2 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
6.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
6.3.1 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
6.3.2 United States Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
7.2 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
7.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country
7.3.1 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
7.3.2 Germany Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.3 France Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region
8.3.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region (2016-2026)
8.3.2 China Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.5 India Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
9.2 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
9.3 South America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
9.3.1 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
9.3.2 Brazil Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country
10.3.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
10.3.2 Turkey Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Hepatitis A Virus Cellular Receptor 2 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) by Region (2016-2021)
Table 5. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region (2021-2026)
Table 6. Aurigene Discovery Technologies Ltd Corporate Information, Head Office, and Major Competitors
Table 7. Aurigene Discovery Technologies Ltd Major Business
Table 8. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 9. Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. BeiGene Ltd Corporate Information, Head Office, and Major Competitors
Table 11. BeiGene Ltd Major Business
Table 12. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 13. BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Eli Lilly and Co Corporate Information, Head Office, and Major Competitors
Table 15. Eli Lilly and Co Major Business
Table 16. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 17. Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Enumeral Biomedical Holdings Inc Corporate Information, Head Office, and Major Competitors
Table 19. Enumeral Biomedical Holdings Inc Major Business
Table 20. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 21. Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Incyte Corp Corporate Information, Head Office, and Major Competitors
Table 23. Incyte Corp Major Business
Table 24. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 25. Incyte Corp Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Interprotein Corp Corporate Information, Head Office, and Major Competitors
Table 27. Interprotein Corp Major Business
Table 28. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 29. Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Jounce Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 31. Jounce Therapeutics Inc Major Business
Table 32. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 33. Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Merus NV Corporate Information, Head Office, and Major Competitors
Table 35. Merus NV Major Business
Table 36. Merus NV Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 37. Merus NV Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Novartis AG Corporate Information, Head Office, and Major Competitors
Table 39. Novartis AG Major Business
Table 40. Novartis AG Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 41. Novartis AG Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sorrento Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 43. Sorrento Therapeutics Inc Major Business
Table 44. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 45. Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Sutro Biopharma Inc Corporate Information, Head Office, and Major Competitors
Table 47. Sutro Biopharma Inc Major Business
Table 48. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 49. Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Tesaro Inc Corporate Information, Head Office, and Major Competitors
Table 51. Tesaro Inc Major Business
Table 52. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 53. Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Trellis Bioscience Inc Corporate Information, Head Office, and Major Competitors
Table 55. Trellis Bioscience Inc Major Business
Table 56. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
Table 57. Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) by Players (2019-2021)
Table 59. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Players (2019-2021)
Table 60. Breakdown of Hepatitis A Virus Cellular Receptor 2 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Hepatitis A Virus Cellular Receptor 2 Players Head Office, Products and Services Provided
Table 62. Hepatitis A Virus Cellular Receptor 2 Mergers & Acquisitions in the Past Five Years
Table 63. Hepatitis A Virus Cellular Receptor 2 New Entrants and Expansion Plans
Table 64. Global Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) by Type (2016-2021)
Table 65. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Type (2016-2021)
Table 66. Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Type (2021-2026)
Table 67. Global Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021)
Table 68. Global Hepatitis A Virus Cellular Receptor 2 Revenue Forecast by Application (2021-2026)
Table 69. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Hepatitis A Virus Cellular Receptor 2 Picture
Figure 2. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type in 2020
Figure 3. IMM-1802
Figure 4. LY-3321367
Figure 5. MCLA-134
Figure 6. CA-170
Figure 7. CA-327
Figure 8. ENUM-005
Figure 9. Others
Figure 10. Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application in 2020
Figure 11. Colon Cancer Picture
Figure 12. Myelodysplastic Picture
Figure 13. Non-Small Cell Lung Cancer Picture
Figure 14. Others Picture
Figure 15. Global Hepatitis A Virus Cellular Receptor 2 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 16. Global Hepatitis A Virus Cellular Receptor 2 Revenue and Forecast (2016-2026) & (USD Million)
Figure 17. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region (2016-2026)
Figure 18. Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region in 2020
Figure 19. North America Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Europe Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. South America Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Hepatitis A Virus Cellular Receptor 2 Market Drivers
Figure 25. Hepatitis A Virus Cellular Receptor 2 Market Restraints
Figure 26. Hepatitis A Virus Cellular Receptor 2 Market Trends
Figure 27. Aurigene Discovery Technologies Ltd Recent Developments and Future Plans
Figure 28. BeiGene Ltd Recent Developments and Future Plans
Figure 29. Eli Lilly and Co Recent Developments and Future Plans
Figure 30. Enumeral Biomedical Holdings Inc Recent Developments and Future Plans
Figure 31. Incyte Corp Recent Developments and Future Plans
Figure 32. Interprotein Corp Recent Developments and Future Plans
Figure 33. Jounce Therapeutics Inc Recent Developments and Future Plans
Figure 34. Merus NV Recent Developments and Future Plans
Figure 35. Novartis AG Recent Developments and Future Plans
Figure 36. Sorrento Therapeutics Inc Recent Developments and Future Plans
Figure 37. Sutro Biopharma Inc Recent Developments and Future Plans
Figure 38. Tesaro Inc Recent Developments and Future Plans
Figure 39. Trellis Bioscience Inc Recent Developments and Future Plans
Figure 40. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Players in 2020
Figure 41. Hepatitis A Virus Cellular Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Hepatitis A Virus Cellular Receptor 2 Revenue Market Share in 2020
Figure 43. Global Top 10 Players Hepatitis A Virus Cellular Receptor 2 Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Type in 2020
Figure 46. Global Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Type (2021-2026)
Figure 47. Global Hepatitis A Virus Cellular Receptor 2 Revenue Share by Application in 2020
Figure 48. Global Hepatitis A Virus Cellular Receptor 2 Market Share Forecast by Application (2021-2026)
Figure 49. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2016-2026)
Figure 50. North America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2016-2026)
Figure 51. North America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2016-2026)
Figure 52. United States Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2016-2026)
Figure 56. Europe Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2016-2026)
Figure 57. Europe Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2016-2026)
Figure 58. Germany Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Region (2016-2026)
Figure 66. China Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2016-2026)
Figure 73. South America Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2016-2026)
Figure 74. South America Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Hepatitis A Virus Cellular Receptor 2 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source

---